Multiple Myeloma: present facts and future expectations The 10th Anniversary of Polish Myeloma Study Group May 21-23, 2015 Lublin, Poland Honour Committee: Rector of the Medical University of Lublin: Prof. Andrzej Drop Marshal of the Lubelskie Voivodeship: Sławomir Sosnowski Mayor of the City of Lublin: Krzysztof Żuk Scientific Committee: Prof. Anna Dmoszyńska - chair Prof. Aleksander Skotnicki Prof. Wiesław W. Jędrzejczak Prof. Lidia Usnarska-Zubkiewicz Prof. Tadeusz Robak Prof. Jan Walewski Organizing Committe Prof. Krzysztof Giannopoulos - chair Prof. Marek Hus Dr Adam Walter-Croneck, Dr Paulina Własiuk Programme Thursday – May 21st , 2015 20.00 Welcome dinner Friday – May 22nd , 2015 8.30-8.45 Welcome address and short history of Polish Myeloma Study Group – Anna Dmoszyńska 8.45 – 10.15 Short presentation of European Myeloma Study Groups Chairmen: Heinz Ludwig (Austria), Tadeusz Robak (Poland) IFM - Intergroupe Francophone du Myelome Group - Philippe Moreau (France) PETHEMA (Programa para el Estudio y la Terapéutica de las Hemopatías Malignas) Group – Maria Victoria Mateos (Spain) Central European Myeloma Study Group – Heinz Ludwig (Austria) The Nordic Myeloma Group – Torben Plesner (Denmark) EBMT Group - Gosta Gahrton (Sweden) HOVON (The Haemato Oncology Foundation for Adults in the Netherlands) Group – Pieter Sonneveld (Netherlands) The Greek Myeloma Study Group – Evangelos Terpos (Greece) The Czech Myeloma Group – Roman Hajek (Czech Republik) 10.15-10.45 Coffee break 10.45 – 12.15 Short presentation of Polish Myeloma Study Group achievements – Chairmen: Anna Dmoszyńska (Poland), Aleksander Skotnicki (Poland) Value of cytogenetic assessment in treatment decisions and prognostification: on behalf of Polish Myeloma Study Group Norbert Grząśko (20 minutes) Multicenter clinical trials: Induction therapy with cyclophosphamide, thalidomide and dexamethasone in Poland: on behalf of Polish Myeloma Study Group Adam WalterCroneck (10 minutes) Bortezomib-based regiment for relapsed/refractory multiple myeloma patients: on behalf of Polish Myeloma Study Group Adam Walter-Croneck, – (15 minutes), Lenalidomide-based therapy for multiple myeloma patients – Polish experience: on behalf of Polish Myeloma Study Group Lidia Usnarska-Zubkiewicz (15 minutes) Immune defects in multiple myeloma: on behalf of Polish Myeloma Study Group Krzysztof Giannopoulos (15 minutes) 12.15-13.45 Satellite session I 13.45 -14.45 Lunch 14.45 – 15.45 Satellite session II 15.45. – 16.45 Expert Panel I – The role of cytogenetic abnormalities in the treatment decisions Chair: Phillipe Moreau, Participants: Pieter Sonneveld, Roman Hajek , Anna Dmoszyńska, Tomasz Wróbel, Olga Haus, Dominik Dytfeld 16.45-17.00 Coffee break 17.00. – 18.00 Expert Panel II – Bone lesions: diagnosis and treatment Chair: Evangelos Terpos, Participants: Maria Victoria Mateos, Torben Plesner, Lidia Usnarska-Zubkiewicz, Artur Jurczyszyn, Iwona Hus, Bogdan Małkowski 19.30 the Concert at Old Theatre in Old City of Lublin 20.30 Dinner Saturday – May 23th , 2015 8.30 – 10.00 Expert Panel III – Multiple myeloma: the current knowledge and future perspectives Chair: Gosta Gahrton, Participants: Philippe Moreau, Heinz Ludwig, Wiesław Wiktor Jędrzejczak, Krzysztof Giannopoulos, Krzysztof Jamroziak, Jerzy Hołowiecki, Andrzej Jakubowiak 10.00-11.00 Satellite session III 11.00 -12.00 Plans for Cooperation: Carfilzomib – rationale option for relapsed/refractory multiple myeloma Andrzej Jakubowiak Consolidation with carfilzomib, lenalidomide and dexamethasone after autologous stem cell transplantation: multicentre research proposal of Polish Myeloma Consortium – Dominik Dytfeld 12.00 End of the meeting